Article
PERK: a novel therapeutic target for neurodegenerative diseases?
29 May 2014
Abstract excerpt
Identification of therapeutic targets based on novel mechanistic studies is urgently needed for neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease, and prion disease. Multiple lines of evidence have emerged to suggest that inhibition of the stress-induced endoplasmic reticulum kinase PERK (protein kinase RNA-like endoplasmic reticulum kinase) is a potential therapeutic strategy for these...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
